Committee for Orphan Medicinal Products (COMP): 3-5 November 2020
Date:
03/11/2020 to 05/11/2020
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.